GlassScriptPhysician profile
David Hyndman
NPI 1386672160
$2,854.95
in general payments reported to CMS, 2019-2025
15 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $155 · 2021: $471 · 2022: $458 · 2023: $514 · 2024: $507 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365 · Entertainment: $35.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.97 |
| Entertainment | $35.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $761.38 | 2019-2025 | Tryptyr, Clareon, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $332.50 | 2019-2021 | |
| Biotissue Holdings INC. | $250.01 | 2021 | |
| Coopervision INC. | $247.74 | 2023-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $213.81 | 2022-2024 | Infuse |
| Tarsus Pharmaceuticals, INC. | $196.79 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $157.51 | 2022 | |
| Abbvie INC. | $144.18 | 2022-2025 | |
| Rxsight INC | $129.49 | 2022-2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Mallinckrodt Hospital Products INC. | $129.33 | 2023 | Acthar |
| Lkc Technologies, INC. | $117.33 | 2024 | |
| Derma Sciences, INC. | $66.11 | 2019 | |
| Glaukos Corporation | $55.82 | 2021 | |
| Optos, INC. | $35.71 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hyndman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.